Treatment-Emergent Central Sleep Apnea: When CPAP Causes Central Events

What Is Treatment-Emergent Central Sleep Apnea?

You started CPAP to treat obstructive sleep apnea. Your obstructive events dropped. But now your data shows a new problem: central apneas that weren't there before. This is called treatment-emergent central sleep apnea (TECSA), sometimes referred to as complex sleep apnea.

Unlike obstructive apneas, where your airway physically collapses, central apneas happen when your brain temporarily stops sending the signal to breathe. Your airway is open. Your muscles just don't receive the command to inhale. During a central apnea, there is no effort to breathe at all for 10 or more seconds.

TECSA is specifically defined as central sleep apnea that appears or worsens after starting positive airway pressure therapy in a patient who was originally diagnosed with obstructive sleep apnea. The International Classification of Sleep Disorders (ICSD-3) classifies it as a distinct condition: central apneas that emerge during PAP therapy, with a central apnea index of 5 or more events per hour, and where the central events are not better explained by another medical condition.

How Common Is TECSA?

Research suggests TECSA occurs in approximately 5 to 15% of patients who begin CPAP therapy for obstructive sleep apnea. A landmark 2006 study by Morgenthaler et al. published in Sleep found that roughly 6.5% of patients referred for CPAP titration developed treatment-emergent central apneas. A later meta-analysis published in the Journal of Clinical Sleep Medicine (Cassel et al., 2011) placed the prevalence between 5% and 20%, depending on how strictly the condition was defined.

Certain groups appear to be at higher risk:

• Men are more likely to develop TECSA than women
• Patients with severe obstructive sleep apnea (higher baseline AHI)
• Patients with coronary artery disease or heart failure
• Patients already showing some central apneas during their diagnostic sleep study
• Those using opioid medications, which suppress respiratory drive

If you are new to CPAP and seeing central apneas in your data, you are not alone. This is a recognized and well-studied phenomenon.

Why Does CPAP Cause Central Apneas?

Your body's breathing is controlled by a feedback loop involving carbon dioxide (CO2) levels in your blood. When CO2 rises, chemoreceptors in your brainstem trigger a stronger breathing response. When CO2 falls, the drive to breathe weakens.

Here is where CPAP creates a disruption. When you have untreated obstructive sleep apnea, your body adapts to a pattern of intermittent airway blockages and oxygen drops. Your CO2 levels run higher than normal, and your respiratory control system calibrates itself to that baseline.

When CPAP eliminates the obstructive events, several things happen at once:

1. CO2 levels drop because you are now ventilating efficiently all night
2. Your CO2 apneic threshold shifts. The level of CO2 below which your brain stops sending the breathing signal is now closer to your normal sleeping CO2 level
3. The "loop gain" of your respiratory control system increases. Small fluctuations in CO2 produce exaggerated breathing responses, leading to cycles of overbreathing and underbreathing

The result is a pattern where your breathing alternates between too much and too little. During the "too little" phases, your brain may stop sending the breathing signal entirely, producing a central apnea. This instability is most common during lighter stages of sleep and during the transition from wakefulness to sleep.

Think of it like a thermostat that has been recalibrated. Your body's respiratory "set point" needs time to find its new equilibrium with the obstruction removed.

How to Recognize TECSA in Your Data

When you import your SD card data into CPAP Clarity, the Event Breakdown on your dashboard shows exactly how many obstructive, central, and mixed apneas occurred during each session. Here is what the TECSA pattern typically looks like:

• Obstructive events decrease compared to your pre-CPAP baseline or early therapy nights
• Central apneas increase or appear for the first time, often within the first few weeks of therapy
• The central apnea index (CAI) rises above 5 per hour in clear TECSA cases
• Central events cluster during lighter sleep stages, especially early in the night or during sleep-stage transitions
• Your overall AHI may not improve as expected, because central events are replacing the obstructive ones you eliminated

The Event Timeline visualization is especially useful here. Look for central apneas that appear in recurring clusters, sometimes with a crescendo-decrescendo breathing pattern between events. This cyclic pattern is characteristic of the respiratory control instability that drives TECSA.

Analyze your event breakdown for free with CPAP Clarity →

When Not to Worry

In the majority of cases, TECSA is temporary. Research published in Sleep Medicine (Javaheri et al., 2009) found that treatment-emergent central apneas resolve spontaneously in roughly 50 to 60% of patients within the first 3 months of consistent CPAP use. Other studies have placed resolution rates even higher when patients maintain strong adherence.

Signs that your TECSA is likely resolving on its own:

• Your central apnea index is trending downward week over week
• You have been on CPAP for fewer than 3 months
• You don't have underlying heart failure or other cardiac conditions
• You are not taking opioid medications
• Your total AHI is still improving overall, even if some central events remain

A handful of central apneas per night is normal for any CPAP user. Even people without sleep apnea have occasional central events during sleep, particularly at sleep onset. The key metric to track is the trend over time, not any single night.

If your central events are declining, your body is adjusting exactly as expected. Keep using your machine consistently, track your data, and give your respiratory control system time to recalibrate.

When to Worry

Not all TECSA resolves on its own. In a subset of patients (estimates vary, but roughly 1.5 to 3.5% of all CPAP users), central apneas persist beyond the initial adaptation period and require a change in therapy.

Red flags that suggest persistent TECSA:

• Your central apnea index remains above 5 per hour after 3 or more months of consistent CPAP use
• Central apneas are increasing over time rather than decreasing
• You are experiencing symptoms despite good CPAP adherence: excessive daytime sleepiness, frequent nighttime awakenings, morning headaches, or non-restorative sleep
• You have a history of heart failure, atrial fibrillation, or stroke, conditions that increase the risk of persistent central apneas
• You are taking opioid medications, which can independently suppress respiratory drive

Persistent TECSA matters because central apneas cause the same oxygen desaturations and sleep fragmentation as obstructive events. If your CPAP is eliminating obstructive events but central events are keeping your AHI elevated, you are not getting the full benefit of therapy.

When to Talk to Your Doctor

Bring your CPAP data to your sleep physician if any of the following apply:

• Your central apnea index has been above 5 per hour for more than 8 to 12 weeks
• Your overall AHI is not improving despite good mask seal and adequate pressure settings
• You are experiencing persistent daytime sleepiness, morning headaches, or frequent awakenings
• You have heart failure, atrial fibrillation, or a history of stroke
• You are on opioid therapy
• You feel worse on CPAP than you did before starting therapy

Your CPAP data gives you the information you need to have a specific, productive conversation with your provider. Rather than saying "I don't feel better," you can show them your event breakdown, your central apnea trend, and your nightly AHI history. This is exactly the kind of data that helps sleep physicians make informed treatment decisions.

Monitoring your oxygen saturation overnight can also provide useful information for your doctor. A fingertip pulse oximeter (opens in new tab) won't replace a formal sleep study, but it can help you and your provider identify whether central events are causing meaningful oxygen drops.

Treatment Options for Persistent TECSA

If TECSA does not resolve on its own, your sleep physician has several options. All of these are prescription therapies that require a provider's guidance.

Adaptive Servo-Ventilation (ASV)

ASV is the most common treatment for persistent TECSA. Unlike standard CPAP, which delivers a constant or auto-adjusting pressure, ASV actively monitors your breathing pattern breath by breath. When it detects a central apnea or reduced respiratory effort, it increases pressure support to deliver a backup breath. When your breathing is normal, it backs off.

Research published in the Journal of Clinical Sleep Medicine (Allam et al., 2007) demonstrated that ASV significantly reduces central apnea index and improves overall AHI in TECSA patients compared to continued CPAP therapy. The ResMed AirCurve ASV is one of the most widely prescribed devices in this category.

Critical safety note (SERVE-HF): ASV is contraindicated in patients with heart failure and reduced ejection fraction (left ventricular EF below 45%). The SERVE-HF trial, a large randomized controlled study published in the New England Journal of Medicine (Cowie et al., 2015), found that ASV was associated with increased cardiovascular mortality in this specific population. If you have heart failure, your cardiologist and sleep physician must coordinate before any therapy change. This is not optional.

BiPAP ST (Spontaneous-Timed)

BiPAP with a backup rate (BiPAP ST) provides two pressure levels (higher for inhalation, lower for exhalation) and includes a timed backup breathing rate. If your brain fails to initiate a breath within a set interval, the machine triggers one for you. This approach can be effective for some TECSA patients, particularly those who cannot use ASV due to the SERVE-HF contraindication.

Pressure Optimization

In some cases, adjusting CPAP pressure can reduce TECSA without switching devices. Over-pressurization is a known contributor to central apneas. If your auto-CPAP is delivering pressures higher than necessary, the excess ventilation can worsen respiratory control instability. Your sleep physician may narrow your pressure range or adjust your EPR (Expiratory Pressure Relief) setting. This is a clinical decision that requires a provider's assessment of your data.

Positional Therapy

Some TECSA patients find that sleeping position influences their central apnea frequency. Research suggests that central apneas can be more frequent in the supine (back-sleeping) position in some individuals. Sleeping on your side may reduce events, though this is not a standalone treatment for significant TECSA. A CPAP-compatible pillow (opens in new tab) with mask cutouts can make side sleeping more comfortable and help maintain a good mask seal.

Medication (Acetazolamide)

In select cases, sleep physicians may prescribe acetazolamide, a carbonic anhydrase inhibitor that lowers the CO2 apneic threshold and stabilizes respiratory control. A study by Javaheri (2006) published in Sleep showed that acetazolamide reduced central apnea index in patients with idiopathic central sleep apnea. This is a prescription medication with potential side effects, and it is not a first-line treatment for TECSA.

Living with TECSA: Practical Tips

While you and your provider work through treatment optimization, there are several things you can do to support your therapy:

• Use your CPAP consistently. The data clearly shows that adherence is the single most important factor in TECSA resolution. Skipping nights resets the adaptation process.
• Track your data regularly. Import your SD card data into CPAP Clarity and watch the central apnea trend over weeks, not individual nights. Night-to-night variation is normal. The trajectory matters.
• Avoid alcohol before bed. Alcohol destabilizes respiratory control and can worsen central apneas. Research supports avoiding alcohol for at least 3 to 4 hours before sleep.
• Discuss your medications with your provider. Opioids, benzodiazepines, and certain other medications can worsen central apneas. Never adjust medications on your own, but make sure your sleep physician knows your full medication list.
• Monitor your sleep position. If you notice more central events on nights when you sleep on your back, consider trying a contoured CPAP pillow (opens in new tab) that encourages side sleeping.

The Bottom Line

Treatment-emergent central sleep apnea is a common, well-documented response to starting CPAP therapy. It affects roughly 5 to 15% of new CPAP users. In the majority of cases, it resolves on its own within weeks to months as your body's respiratory control system adapts to efficient breathing without obstruction.

The most important thing you can do is track the trend. Use your CPAP data to monitor your central apnea index over time. If it is declining, you are on the right path. If it persists beyond 3 months, or if you have risk factors like heart disease or opioid use, bring your data to your sleep physician. Treatments like ASV and BiPAP ST are highly effective for persistent cases, and your detailed event data helps your provider choose the right approach.

Understanding what is happening in your body, and having the data to prove it, is one of the most powerful things you can do as an engaged CPAP user.